Inclusion body myositis: A view from the caenorhabditis elegans muscle

Molecular Neurobiology

Volumn 38, Issue 2, 2008, Pages 178-198

  Rebolledo, D L ^a   Minniti, A N ^a   Grez, P M ^a   Fadic, R ^b   Kohn, R ^c   Inestrosa, N C ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c URSINUS COLLEGE   (United States)

Author keywords

A peptide; C. elegans; IBM; Inclusion Body Myositis; Invertebrate models; Muscle; Myopathy

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN[25-35]; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; AZATHIOPRINE; BETA SECRETASE; CASEIN KINASE I; CHOLESTEROL; CLIOQUINOL; CORTICOSTEROID; CRYSTALLIN; CYCLOSPORIN A; ETANERCEPT; GINKGO BILOBA EXTRACT; GINKGOLIDE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MITOGEN ACTIVATED PROTEIN KINASE; PRESENILIN 1; PROTEIN NOGO; TAU PROTEIN; UBIQUITIN; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; METAL; PEPTIDE;

ALZHEIMER DISEASE; CAENORHABDITIS ELEGANS; CLINICAL TRIAL; CULTURE TECHNIQUE; GENE; GENETIC SCREENING; GINKGO BILOBA; HUMAN; INCLUSION BODY MYOSITIS; INFLAMMATION; KNOCKOUT GENE; LIFE CYCLE; MITOCHONDRION; MOLECULAR MECHANICS; MORPHOLOGY; MOUSE STRAIN; MUSCLE CELL; MYOPATHY; NERVE CELL PLASTICITY; NEUROMUSCULAR DISEASE; NONHUMAN; OXIDATIVE STRESS; PARALYSIS; PRION; PROTEIN EXPRESSION; REVIEW; ANIMAL; DISEASE MODEL; GENETICS; HISTOLOGY; METABOLISM; MUSCLE; PATHOLOGY; RNA INTERFERENCE;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; HUMANS; METALS; MITOCHONDRIA; MUSCLES; MYOSITIS, INCLUSION BODY; OXIDATIVE STRESS; PEPTIDES; RNA INTERFERENCE;

EID: 58149171471     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12035-008-8041-0     Document Type: Review

References (223)

1. DJ Selkoe (2007) Developing preventive therapies for chronic diseases: lessons learned from Alzheimer's disease Nutr Rev 65 S239 S243
2. DJ Selkoe (2001) Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 741 766
3. WK Engel V Askanas (2006) Inclusion-body myositis: clinical, diagnostic, and pathologic aspects Neurology 66 S20 S29
4. V Askanas WK Engel (2007) Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis Curr Opin Rheumatol 19 550 559
5. C Haass DJ Selkoe (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide Nat Rev Mol Cell Biol 8 101 112
6. S Brenner (2003) Nature's gift to science (Nobel lecture) Chembiochem 4 683 687
7. E Culetto DB Sattelle (2000) A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes Hum Mol Genet 9 869 877
8. DL Riddle T Blumenthal BJ Meyer JR Priess (1997)
9. IA Hope (1999)
10. D Crawford N Libina C Kenyon (2007) Caenorhabditis elegans integrates food and reproductive signals in lifespan determination Aging Cell 6 715 721
11. A Ghazi S Henis-Korenblit C Kenyon (2007) Regulation of Caenorhabditis elegans lifespan by a proteasomal E3 ligase complex Proc Natl Acad Sci U S A 104 5947 5952
12. M Hansen A Chandra LL Mitic B Onken M Driscoll C Kenyon (2008) A role for autophagy in the extension of lifespan by dietary restriction in C. elegans PLoS Genet 4 e24
13. F Broue P Liere C Kenyon EE Baulieu (2007) A steroid hormone that extends the lifespan of Caenorhabditis elegans Aging Cell 6 87 94
14. M Hansen AL Hsu A Dillin C Kenyon (2005) New genes tied to endocrine, metabolic, and dietary regulation of lifespan from a Caenorhabditis elegans genomic RNAi screen PLoS Genet 1 119 128
15. JE Sulston HR Horvitz (1977) Post-embryonic cell lineages of the nematode, Caenorhabditis elegans Dev Biol 56 110 156
16. HR Horvitz (2003) Worms, life, and death (Nobel lecture) Chembiochem 4 697 711
17. MM Metzstein GM Stanfield HR Horvitz (1998) Genetics of programmed cell death in C. elegans: past, present and future Trends Genet 14 410 416
18. JE Sulston (2003) Caenorhabditis elegans: the cell lineage and beyond (Nobel lecture) Chembiochem 4 688 696
19. UA Badrising ML Maat-Schieman JC van Houwelingen (2005) Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients J Neurol 252 1448 1454
20. RD Adams BA Kakulas FA Samaha (1965) A myopathy with cellular inclusions Trans Am Neurol Assoc 90 213 216
21. BP Lotz AG Engel H Nishino JC Stevens WJ Litchy (1989) Inclusion body myositis. Observations in 40 patients Brain 112 (Pt 3) 727 747
22. D Figarella-Branger M Civatte C Bartoli JF Pellissier (2003) Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies Muscle Nerve 28 659 682
23. HE Neville LL Baumbach SP Ringel LS Russo Jr. E Sujansky CA Garcia (1992) Familial inclusion body myositis: evidence for autosomal dominant inheritance Neurology 42 897 902
24. J McFerrin WK Engel V Askanas (1998) Impaired innervation of cultured human muscle overexpressing betaAPP experimentally and genetically: relevance to inclusion-body myopathies Neuroreport 9 3201 3205
25. V Askanas RB Alvarez WK Engel (1993) Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis Ann Neurol 34 551 560
26. V Askanas WK Engel (1993) New advances in inclusion-body myositis Curr Opin Rheumatol 5 732 741
27. M Needham FL Mastaglia MJ Garlepp (2007) Genetics of inclusion-body myositis Muscle Nerve 35 549 561
28. BM Koffman K Sivakumar T Simonis D Stroncek MC Dalakas (1998) HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies J Neuroimmunol 84 139 142
29. B Ranque-Francois T Maisonobe E Dion (2005) Familial inflammatory inclusion body myositis Ann Rheum Dis 64 634 637
30. CU Hubbers CS Clemen K Kesper (2007) Pathological consequences of VCP mutations on human striated muscle Brain 130 381 393
31. C Lindberg E Trysberg A Tarkowski A Oldfors (2003) Anti-T-lymphocyte globulin treatment in inclusion body myositis: a randomized pilot study Neurology 61 260 262
32. J Schmidt G Rakocevic R Raju MC Dalakas (2004) Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity Brain 127 1182 1190
33. K Amemiya RP Granger MC Dalakas (2000) Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies Brain 123 (Pt 10) 2030 2039
34. R Raju O Vasconcelos R Granger MC Dalakas (2003) Expression of IFN-gamma-inducible chemokines in inclusion body myositis J Neuroimmunol 141 125 131
35. MC Dalakas (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases JAMA 291 2367 2375
36. V Askanas WK Engel M Bilak RB Alvarez DJ Selkoe (1994) Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau Am J Pathol 144 177 187
37. V Askanas WK Engel (2001) Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease J Neuropathol Exp Neurol 60 1 14
38. V Askanas WK Engel (2002) Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease Curr Rheumatol Rep 4 427 433
39. A Broccolini WK Engel RB Alvarez V Askanas (2000) Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein Am J Pathol 156 1151 1155
40. GM Wilczynski WK Engel V Askanas (2000) Association of active extracellular signal-regulated protein kinase with paired helical filaments of inclusion-body myositis muscle suggests its role in inclusion-body myositis tau phosphorylation Am J Pathol 156 1835 1840
41. T Kumamoto H Ueyama H Tsumura I Toyoshima T Tsuda (2004) Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis Acta Neuropathol 107 59 65
42. K Fukuchi D Pham M Hart L Li JR Lindsey (1998) Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy Am J Pathol 153 1687 1693
43. C Morgan M Colombres MT Nunez NC Inestrosa (2004) Structure and function of amyloid in Alzheimer's disease Prog Neurobiol 74 323 349
44. C Soto MC Branes J Alvarez NC Inestrosa (1994) Structural determinants of the Alzheimer's amyloid beta-peptide J Neurochem 63 1191 1198
45. V Askanas WK Engel RB Alvarez (1993) Enhanced detection of Congo-Red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique Neurology 43 1265 1267
46. MC Dalakas B Koffman M Fujii S Spector K Sivakumar E Cupler (2001) A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM Neurology 56 323 327
47. RJ Barohn L Herbelin JT Kissel (2006) Pilot trial of etanercept in the treatment of inclusion-body myositis Neurology 66 S123 S124
48. MS Wolfe (2008) Gamma-secretase: structure, function, and modulation for Alzheimer's disease Curr Top Med Chem 8 2 8
49. YW Zhang H Xu (2007) Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism Curr Mol Med 7 687 696
50. LW Jin MG Hearn CE Ogburn (1998) Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis Am J Pathol 153 1679 1686
51. M Tateyama A Takeda Y Onodera (2003) Oxidative stress and predominant Abeta42(43) deposition in myopathies with rimmed vacuoles Acta Neuropathol 105 581 585
52. JD Lunemann J Schmidt D Schmid (2007) Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis Ann Neurol 61 476 483
53. K Iqbal C Alonso Adel S Chen (2005) Tau pathology in Alzheimer disease and other tauopathies Biochim Biophys Acta 1739 198 210
54. M Mirabella RB Alvarez M Bilak WK Engel V Askanas (1996) Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies J Neuropathol Exp Neurol 55 774 786
55. JJ Pei H Braak WL An (2002) Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease Brain Res Mol Brain Res 109 45 55
56. SD Gross RA Anderson (1998) Casein kinase I: spatial organization and positioning of a multifunctional protein kinase family Cell Signal 10 699 711
57. H Flotow PR Graves AQ Wang CJ Fiol RW Roeske PJ Roach (1990) Phosphate groups as substrate determinants for casein kinase I action J Biol Chem 265 14264 14269
58. VV Risnik G Adam NB Gusev P Friedrich (1988) Casein kinases I and II bound to pig brain microtubules Cell Mol Neurobiol 8 315 324
59. G Li H Yin J Kuret (2004) Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules J Biol Chem 279 15938 15945
60. N Ghoshal JF Smiley AJ DeMaggio (1999) A new molecular link between the fibrillar and granulovacuolar lesions of Alzheimer's disease Am J Pathol 155 1163 1172
61. TJ Kannanayakal H Tao DD Vandre J Kuret (2006) Casein kinase-1 isoforms differentially associate with neurofibrillary and granulovacuolar degeneration lesions Acta Neuropathol 111 413 421
62. MA Price (2006) CKI, there's more than one: casein kinase I family members in Wnt and Hedgehog signaling Genes Dev 20 399 410
63. A Caricasole A Copani F Caraci (2004) Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain J Neurosci 24 6021 6027
64. N Inestrosa GV De Ferrari JL Garrido (2002) Wnt signaling involvement in beta-amyloid-dependent neurodegeneration Neurochem Int 41 341 344
65. GV De Ferrari NC Inestrosa (2000) Wnt signaling function in Alzheimer's disease Brain Res Brain Res Rev 33 1 12
66. TJ Kannanayakal JR Mendell J Kuret (2008) Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis Neurosci Lett 431 141 145
67. MS Wolfe (2008) Gamma-secretase inhibition and modulation for Alzheimer's disease Curr Alzheimer Res 5 158 164
68. G Evin MF Sernee CL Masters (2006) Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies CNS Drugs 20 351 372
69. V Askanas WK Engel CC Yang RB Alvarez VM Lee T Wisniewski (1998) Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy Am J Pathol 152 889 895
70. R Vassar (2004) BACE1: the beta-secretase enzyme in Alzheimer's disease J Mol Neurosci 23 105 114
71. SL Cole R Vassar (2007) The Alzheimer's disease beta-secretase enzyme, BACE1 Mol Neurodegener 2 22
72. G Vattemi WK Engel J McFerrin JD Buxbaum L Pastorino V Askanas (2001) Presence of BACE1 and BACE2 in muscle fibres of patients with sporadic inclusion-body myositis Lancet 358 1962 1964
73. G Vattemi WK Engel J McFerrin L Pastorino JD Buxbaum V Askanas (2003) BACE1 and BACE2 in pathologic and normal human muscle Exp Neurol 179 150 158
74. W He Y Lu I Qahwash XY Hu A Chang R Yan (2004) Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation Nat Med 10 959 965
75. S Wojcik WK Engel R Yan J McFerrin V Askanas (2007) NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers Acta Neuropathol 114 517 526
76. KA Carson C Geula MM Mesulam (1991) Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue Brain Res 540 204 208
77. C Geula BD Greenberg MM Mesulam (1994) Cholinesterase activity in the plaques, tangles and angiopathy of Alzheimer's disease does not emanate from amyloid Brain Res 644 327 330
78. NC Inestrosa R Alarcon (1998) Molecular interactions of acetylcholinesterase with senile plaques J Physiol Paris 92 341 344
79. A Alvarez R Alarcon C Opazo (1998) Stable complexes involving acetylcholinesterase and amyloid-beta peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils J Neurosci 18 3213 3223
80. NC Inestrosa A Alvarez F Calderon (1996) Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments Mol Psychiatry 1 359 361
81. NC Inestrosa A Alvarez CA Perez (1996) Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme Neuron 16 881 891
82. A Alvarez F Bronfman CA Perez M Vicente J Garrido NC Inestrosa (1995) Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides Neurosci Lett 201 49 52
83. A Alvarez C Opazo R Alarcon J Garrido NC Inestrosa (1997) Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils J Mol Biol 272 348 361
84. GV De Ferrari MA Canales I Shin LM Weiner I Silman NC Inestrosa (2001) A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation Biochemistry 40 10447 10457
85. AE Reyes MA Chacon MC Dinamarca W Cerpa C Morgan NC Inestrosa (2004) Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss Am J Pathol 164 2163 2174
86. T Rees PI Hammond H Soreq S Younkin S Brimijoin (2003) Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex Neurobiol Aging 24 777 787
87. NC Inestrosa JP Sagal M Colombres (2005) Acetylcholinesterase interaction with Alzheimer amyloid beta Subcell Biochem 38 299 317
88. NC Inestrosa MC Dinamarca A Alvarez (2008) Amyloid-cholinesterase interactions. Implications for Alzheimer's disease Febs J 275 625 632
89. V Askanas WK Engel (2003) Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging J Child Neurol 18 185 190
90. ER Frears DJ Stephens CE Walters H Davies BM Austen (1999) The role of cholesterol in the biosynthesis of beta-amyloid Neuroreport 10 1699 1705
91. M Jaworska-Wilczynska GM Wilczynski WK Engel DK Strickland KH Weisgraber V Askanas (2002) Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle Neurology 58 438 445
92. V Askanas M Mirabella WK Engel RB Alvarez KH Weisgraber (1994) Apolipoprotein E immunoreactive deposits in inclusion-body muscle diseases Lancet 343 364 365
93. M Mirabella RB Alvarez WK Engel KH Weisgraber V Askanas (1996) Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies Ann Neurol 40 864 872
94. NC Inestrosa MP Marzolo AB Bonnefont (1998) Cellular and molecular basis of estrogen's neuroprotection. Potential relevance for Alzheimer's disease Mol Neurobiol 17 73 86
95. AD Roses AM Saunders (1997) Apolipoprotein E genotyping as a diagnostic adjunct for Alzheimer's disease Int Psychogeriatr 9 (Suppl 1) 277 288 discussion 317-221
96. AD Roses (2006) On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease J Alzheimers Dis 9 361 366
97. AD Roses (1996) Apolipoprotein E alleles as risk factors in Alzheimer's disease Annu Rev Med 47 387 400
98. A Caruso M Motolese L Iacovelli (2006) Inhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cells J Neurochem 98 364 371
99. G Gossrau B Gestrich R Koch (2004) Apolipoprotein E and alpha-1-antichymotrypsin polymorphisms in sporadic inclusion body myositis Eur Neurol 51 215 220
100. S Albrecht JM Bilbao (1993) Ubiquitin expression in inclusion body myositis. An immunohistochemical study Arch Pathol Lab Med 117 789 793
101. V Askanas P Serdaroglu WK Engel RB Alvarez (1991) Immunolocalization of ubiquitin in muscle biopsies of patients with inclusion body myositis and oculopharyngeal muscular dystrophy Neurosci Lett 130 73 76
102. H Mori J Kondo Y Ihara (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease Science 235 1641 1644
103. G Perry R Friedman G Shaw V Chau (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains Proc Natl Acad Sci U S A 84 3033 3036
104. CC Weihl SE Miller PI Hanson A Pestronk (2007) Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice Hum Mol Genet 16 919 928
105. P Fratta WK Engel J McFerrin KJ Davies SW Lin V Askanas (2005) Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibers Am J Pathol 167 517 526
106. ET Parkin NT Watt I Hussain (2007) Cellular prion protein regulates beta-secretase cleavage of the Alzheimer's amyloid precursor protein Proc Natl Acad Sci U S A 104 11062 11067
107. M Gacia K Safranow M Styczynska (2006) Prion protein gene M129 allele is a risk factor for Alzheimer's disease J Neural Transm 113 1747 1751
108. NC Inestrosa W Cerpa L Varela-Nallar (2005) Copper brain homeostasis: role of amyloid precursor protein and prion protein IUBMB Life 57 645 650
109. L Varela-Nallar EM Toledo LF Larrondo AL Cabral VR Martins NC Inestrosa (2006) Induction of cellular prion protein gene expression by copper in neurons Am J Physiol Cell Physiol 290 C271 281
110. L Varela-Nallar A Gonzalez NC Inestrosa (2006) Role of copper in prion diseases: deleterious or beneficial? Curr Pharm Des 12 2587 2595
111. G Zanusso G Vattemi S Ferrari (2001) Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy Brain Pathol 11 182 189
112. GG Kovacs E Lindeck-Pozza L Chimelli (2004) Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle Ann Neurol 55 121 125
113. E Sarkozi V Askanas WK Engel (1994) Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy Am J Pathol 145 1280 1284
114. S Huang J Liang M Zheng (2007) Inducible overexpression of wild-type prion protein in the muscles leads to a primary myopathy in transgenic mice Proc Natl Acad Sci U S A 104 6800 6805
115. M Bilak V Askanas WK Engel (1993) Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusion-body myositis Acta Neuropathol 85 378 382
116. G Vattemi WK Engel J McFerrin V Askanas (2003) Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles J Neurochem 85 1539 1546
117. FC Crawford MJ Freeman JA Schinka (2000) A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease Neurology 55 763 768
118. U Finckh H von der Kammer J Velden (2000) Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease Arch Neurol 57 1579 1583
119. JJ Mao S Katayama C Watanabe (2001) The relationship between alphaB-crystallin and neurofibrillary tangles in Alzheimer's disease Neuropathol Appl Neurobiol 27 180 188
120. DV Dabir JQ Trojanowski C Richter-Landsberg VM Lee MS Forman (2004) Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology Am J Pathol 164 155 166
121. RC Augusteyn (2004) alpha-crystallin: a review of its structure and function Clin Exp Optom 87 356 366
122. J Horwitz (2003) Alpha-crystallin Exp Eye Res 76 145 153
123. GJ Stege K Renkawek PS Overkamp (1999) The molecular chaperone alphaB-crystallin enhances amyloid beta neurotoxicity Biochem Biophys Res Commun 262 152 156
124. BL Banwell AG Engel (2000) AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis Neurology 54 1033 1041
125. S Wojcik WK Engel J McFerrin O Paciello V Askanas (2006) AbetaPP-overexpression and proteasome inhibition increase alphaB-crystallin in cultured human muscle: relevance to inclusion-body myositis Neuromuscul Disord 16 839 844
126. MM Wilhelmus RM de Waal MM Verbeek (2007) Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease Mol Neurobiol 35 203 216
127. NF Gonzalez-Cadavid S Bhasin (2004) Role of myostatin in metabolism Curr Opin Clin Nutr Metab Care 7 451 457
128. S Wojcik A Nogalska J McFerrin WK Engel G Oledzka V Askanas (2007) Myostatin precursor protein is increased and associates with amyloid-beta precursor protein in inclusion-body myositis culture model Neuropathol Appl Neurobiol 33 238 242
129. S Wojcik WK Engel J McFerrin V Askanas (2005) Myostatin is increased and complexes with amyloid-beta within sporadic inclusion-body myositis muscle fibers Acta Neuropathol 110 173 177
130. S Miranda C Opazo LF Larrondo (2000) The role of oxidative stress in the toxicity induced by amyloid beta-peptide in Alzheimer's disease Prog Neurobiol 62 633 648
131. T Thomas G Thomas C McLendon T Sutton M Mullan (1996) Beta-amyloid-mediated vasoactivity and vascular endothelial damage Nature 380 168 171
132. C Opazo X Huang RA Cherny (2002) Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2) J Biol Chem 277 40302 40308
133. C Behl JB Davis R Lesley D Schubert (1994) Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 817 827
134. MJ Santos RA Quintanilla A Toro (2005) Peroxisomal proliferation protects from beta-amyloid neurodegeneration J Biol Chem 280 41057 41068
135. FH Ruiz M Gonzalez M Bodini C Opazo NC Inestrosa (1999) Cysteine 144 is a key residue in the copper reduction by the beta-amyloid precursor protein J Neurochem 73 1288 1292
136. A Oldfors AR Moslemi L Jonasson M Ohlsson G Kollberg C Lindberg (2006) Mitochondrial abnormalities in inclusion-body myositis Neurology 66 S49 S55
137. K Fukuchi L Ho SG Younkin (1996) High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice Am J Pathol 149 219 227
138. K Fukuchi L Li M Hart JR Lindsey (2000) Accumulation of amyloid-beta protein in exocrine glands of transgenic mice overexpressing a carboxyl terminal portion of amyloid protein precursor Int J Exp Pathol 81 231 239
139. MC Sugarman TR Yamasaki S Oddo (2002) Inclusion body myositis-like phenotype induced by transgenic overexpression of beta APP in skeletal muscle Proc Natl Acad Sci U S A 99 6334 6339
140. MC Sugarman M Kitazawa M Baker VJ Caiozzo HW Querfurth FM LaFerla (2006) Pathogenic accumulation of APP in fast twitch muscle of IBM patients and a transgenic model Neurobiol Aging 27 423 432
141. M Kitazawa KN Green A Caccamo FM LaFerla (2006) Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice Am J Pathol 168 1986 1997
142. M Kitazawa DN Trinh FM Laferla (2008) Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta Ann Neurol 64 15 24
143. MB Feany (2000) Studying human neurodegenerative diseases in flies and worms J Neuropathol Exp Neurol 59 847 856
144. CD Link (2001) Transgenic invertebrate models of age-associated neurodegenerative diseases Mech Ageing Dev 122 1639 1649
145. CD Link (2005) Invertebrate models of Alzheimer's disease Genes Brain Behav 4 147 156
146. I Miguel-Aliaga E Culetto DS Walker HA Baylis DB Sattelle KE Davies (1999) The Caenorhabditis elegans orthologue of the human gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability Hum Mol Genet 8 2133 2143
147. M Chalfie Y Tu G Euskirchen WW Ward DC Prasher (1994) Green fluorescent protein as a marker for gene expression Science 263 802 805
148. A Chapin P Correa M Maguire R Kohn (2007) Synaptic neurotransmission protein UNC-13 affects RNA interference in neurons Biochem Biophys Res Commun 354 1040 1044
149. RS Kamath J Ahringer (2003) Genome-wide RNAi screening in Caenorhabditis elegans Methods 30 313 321
150. A Fire S Xu MK Montgomery SA Kostas SE Driver CC Mello (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans Nature 391 806 811
151. PW Faber JR Alter ME MacDonald AC Hart (1999) Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron Proc Natl Acad Sci U S A 96 179 184
152. SH Satyal E Schmidt K Kitagawa (2000) Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans Proc Natl Acad Sci U S A 97 5750 5755
153. M Lakso S Vartiainen AM Moilanen (2003) Dopaminergic neuronal loss and motor deficits in Caenorhabditis elegans overexpressing human alpha-synuclein J Neurochem 86 165 172
154. T Kuwahara A Koyama K Gengyo-Ando (2006) Familial Parkinson mutant alpha-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans J Biol Chem 281 334 340
155. CD Link (1995) Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans Proc Natl Acad Sci U S A 92 9368 9372
156. RH Waterston (1998)
157. DG Moerman BD Williams (2006) Sarcomere assembly in C. elegans muscle WormBook 16 1 16
158. R Francis RH Waterston (1991) Muscle cell attachment in Caenorhabditis elegans J Cell Biol 114 465 479
159. C Lecroisey L Segalat K Gieseler (2007) The C. elegans dense body: anchoring and signaling structure of the muscle J Muscle Res Cell Motil 28 79 87
160. HF Epstein (1990) Genetic analysis of myosin assembly in Caenorhabditis elegans Mol Neurobiol 4 1 25
161. L Castellani P Vibert C Cohen (1983) Structure of myosin/paramyosin filaments from a molluscan smooth muscle J Mol Biol 167 853 872
162. CJ Beall MA Sepanski EA Fyrberg (1989) Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles Genes Dev 3 131 140
163. MH Lu C DiLullo T Schultheiss (1992) The vinculin/sarcomeric-alpha- actinin/alpha-actin nexus in cultured cardiac myocytes J Cell Biol 117 1007 1022
164. GR Francis RH Waterston (1985) Muscle organization in Caenorhabditis elegans: localization of proteins implicated in thin filament attachment and I-band organization J Cell Biol 101 1532 1549
165. SN Gettner C Kenyon LF Reichardt (1995) Characterization of beta pat-3 heterodimers, a family of essential integrin receptors in C. elegans J Cell Biol 129 1127 1141
166. I Daigle C Li (1993) apl-1, a Caenorhabditis elegans gene encoding a protein related to the human beta-amyloid protein precursor Proc Natl Acad Sci U S A 90 12045 12049
167. SD Styren RL Hamilton GC Styren WE Klunk (2000) X-34, a fluorescent derivative of Congo Red: a novel histochemical stain for Alzheimer's disease pathology J Histochem Cytochem 48 1223 1232
168. CD Link A Taft V Kapulkin (2003) Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model Neurobiol Aging 24 397 413
169. V Fonte V Kapulkin A Taft A Fluet D Friedman CD Link (2002) Interaction of intracellular beta amyloid peptide with chaperone proteins Proc Natl Acad Sci U S A 99 9439 9444
170. EG Stringham D Jones EP Candido (1992) Expression of the polyubiquitin-encoding gene (ubq-1) in transgenic Caenorhabditis elegans Gene 113 165 173
171. CD Link JR Cypser CJ Johnson TE Johnson (1999) Direct observation of stress response in Caenorhabditis elegans using a reporter transgene Cell Stress Chaperones 4 235 242
172. V Fonte DR Kipp J Yerg 3rd (2008) Suppression of in vivo beta-amyloid peptide toxicity by overexpression of the HSP-16.2 small chaperone protein J Biol Chem 283 784 791
173. B Westlund D Parry R Clover M Basson CD Johnson (1999) Reverse genetic analysis of Caenorhabditis elegans presenilins reveals redundant but unequal roles for sel-12 and hop-1 in Notch-pathway signaling Proc Natl Acad Sci U S A 96 2497 2502
174. D Levitan TG Doyle D Brousseau (1996) Assessment of normal and mutant human presenilin function in Caenorhabditis elegans Proc Natl Acad Sci U S A 93 14940 14944
175. HN Cinar KL Sweet KE Hosemann K Earley AP Newman (2001) The SEL-12 presenilin mediates induction of the Caenorhabditis elegans uterine pi cell fate Dev Biol 237 173 182
176. S Eimer R Donhauser R Baumeister (2002) The Caenorhabditis elegans presenilin sel-12 is required for mesodermal patterning and muscle function Dev Biol 251 178 192
177. N Wittenburg S Eimer B Lakowski S Rohrig C Rudolph R Baumeister (2000) Presenilin is required for proper morphology and function of neurons in C. elegans Nature 406 306 309
178. M Arpagaus D Combes E Culetto (1998) Four acetylcholinesterase genes in the nematode Caenorhabditis elegans J Physiol Paris 92 363 367
179. M Grauso E Culetto D Combes Y Fedon JP Toutant M Arpagaus (1998) Existence of four acetylcholinesterase genes in the nematodes Caenorhabditis elegans and Caenorhabditis briggsae FEBS Lett 424 279 284
180. D Combes Y Fedon JP Toutant M Arpagaus (2003) Multiple ace genes encoding acetylcholinesterases of Caenorhabditis elegans have distinct tissue expression Eur J Neurosci 18 497 512
181. J Drake CD Link DA Butterfield (2003) Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid beta-peptide (1-42) in a transgenic Caenorhabditis elegans model Neurobiol Aging 24 415 420
182. L Triguero R Singh R Prabhakar (2008) Molecular dynamics study to investigate the effect of chemical substitutions of methionine 35 on the secondary structure of the amyloid beta (Abeta(1-42)) monomer in aqueous solution J Phys Chem B 112 2159 2167
183. L Hou H Shao Y Zhang (2004) Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation J Am Chem Soc 126 1992 2005
184. G Bitan B Tarus SS Vollers (2003) A molecular switch in amyloid assembly: Met35 and amyloid beta-protein oligomerization J Am Chem Soc 125 15359 15365
185. DS Fay A Fluet CJ Johnson CD Link (1998) In vivo aggregation of beta-amyloid peptide variants J Neurochem 71 1616 1625
186. SM Yatin S Varadarajan CD Link DA Butterfield (1999) In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42) Neurobiol Aging 20 325 330 discussion 339-342
187. K Hensley N Hall R Subramaniam (1995) Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation J Neurochem 65 2146 2156
188. D Boyd-Kimball HF Poon BC Lynn (2006) Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease Neurobiol Aging 27 1239 1249
189. GE Mortimore CM Schworer (1977) Induction of autophagy by amino-acid deprivation in perfused rat liver Nature 270 174 176
190. WH Yu A Kumar C Peterhoff (2004) Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for beta-amyloid peptide over-production and localization in Alzheimer's disease Int J Biochem Cell Biol 36 2531 2540
191. WH Yu AM Cuervo A Kumar (2005) Macroautophagy-a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease J Cell Biol 171 87 98
192. RA Nixon (2007) Autophagy, amyloidogenesis and Alzheimer disease J Cell Sci 120 4081 4091
193. ML Florez-McClure LA Hohsfield G Fonte MT Bealor CD Link (2007) Decreased insulin-receptor signaling promotes the autophagic degradation of beta-amyloid peptide in C. elegans Autophagy 3 569 580
194. Y Wu Z Wu P Butko (2006) Amyloid-beta-induced pathological behaviors are suppressed by Ginkgo biloba extract EGb 761 and ginkgolides in transgenic Caenorhabditis elegans J Neurosci 26 13102 13113
195. C Soto EM Castano B Frangione NC Inestrosa (1995) The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation J Biol Chem 270 3063 3067
196. C Nilsberth A Westlind-Danielsson CB Eckman (2001) The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation Nat Neurosci 4 887 893
197. Grez PA (2005) Obtención y análisis de Cepas Transgénicas de C. elegans. Expresión de péptido Aβ wild-type y sus variantes NIC y Arctic Facultad de Ciencias Químicas y Farmacéuticas. Universidad de Chile, Santiago, Chile, p 56
198. V Praitis E Casey D Collar J Austin (2001) Creation of low-copy integrated transgenic lines in Caenorhabditis elegans Genetics 157 1217 1226
199. MA Deibel WD Ehmann WR Markesbery (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress J Neurol Sci 143 137 142
200. MA Lovell JD Robertson WJ Teesdale JL Campbell WR Markesbery (1998) Copper, iron and zinc in Alzheimer's disease senile plaques J Neurol Sci 158 47 52
201. JM Candy AE Oakley J Klinowski (1986) Aluminosilicates and senile plaque formation in Alzheimer's disease Lancet 1 354 357
202. MA Lovell WD Ehmann WR Markesbery (1993) Laser microprobe analysis of brain aluminum in Alzheimer's disease Ann Neurol 33 36 42
203. DP Perl AR Brody (1980) Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons Science 208 297 299
204. JP Landsberg B McDonald F Watt (1992) Absence of aluminium in neuritic plaque cores in Alzheimer's disease Nature 360 65 68
205. AH Chafi JJ Hauw G Rancurel JP Berry C Galle (1991) Absence of aluminium in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies Neurosci Lett 123 61 64
206. PF Good DP Perl LM Bierer J Schmeidler (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study Ann Neurol 31 286 292
207. PC Ferreira A Piai Kde AM Takayanagui SI Segura-Munoz (2008) Aluminum as a risk factor for Alzheimer's disease Rev Lat Am Enfermagem 16 151 157
208. DL Sparks R Friedland S Petanceska (2006) Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology J Nutr Health Aging 10 247 254
209. AC Miu O Benga (2006) Aluminum and Alzheimer's disease: a new look J Alzheimers Dis 10 179 201
210. D Drago M Bettella S Bolognin (2008) Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease Int J Biochem Cell Biol 40 731 746
211. LF Rodella F Ricci E Borsani (2008) Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain Histol Histopathol 23 433 439
212. AI Bush WH Pettingell G Multhaup (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc Science 265 1464 1467
213. AI Bush WH Pettingell Jr. MD Paradis RE Tanzi (1994) Modulation of A beta adhesiveness and secretase site cleavage by zinc J Biol Chem 269 12152 12158
214. RA Cherny CS Atwood ME Xilinas (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice Neuron 30 665 676
215. CW Ritchie AI Bush A Mackinnon (2003) Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial Arch Neurol 60 1685 1691
216. AR White H Zheng D Galatis (1998) Survival of cultured neurons from amyloid precursor protein knock-out mice against Alzheimer's amyloid-beta toxicity and oxidative stress J Neurosci 18 6207 6217
217. CJ Maynard R Cappai I Volitakis (2002) Overexpression of Alzheimer's disease amyloid-beta opposes the age-dependent elevations of brain copper and iron J Biol Chem 277 44670 44676
218. TA Bayer S Schafer A Simons (2003) Dietary Cu stabilizes brain superoxide dismutase 1 activity and reduces amyloid Abeta production in APP23 transgenic mice Proc Natl Acad Sci U S A 100 14187 14192
219. AL Phinney B Drisaldi SD Schmidt (2003) In vivo reduction of amyloid-beta by a mutant copper transporter Proc Natl Acad Sci U S A 100 14193 14198
220. 2+ neurotoxicity in vivo FASEB J 18 1701 1703
221. W Cerpa L Varela-Nallar AE Reyes AN Minniti NC Inestrosa (2005) Is there a role for copper in neurodegenerative diseases? Mol Aspects Med 26 405 420
222. AI Bush RE Tanzi (2008) Therapeutics for Alzheimer's disease based on the metal hypothesis Neurotherapeutics 5 421 432
223. Y Tsuruta A Furuta N Taniguchi T Yamada J Kira T Iwaki (2002) Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles Acta Neuropathol 103 59 65